An interview by News Medical with David James, CEO J+D Forecasting about pharmaceutical forecasting, J+D Forecasting solutions and their plans for the future.
Generating accurate forecasts for rare diseases can be challenging, especially when the treatable population is in the hundreds and there is little data to get you from one number to the next.
Forecasting is essential in providing clarity on decision making about the future, and good quality forecasts can prevent decisions being made which could be commercially damaging to organisations.
The Context Here at J+D we create 100’s of strategic forecasting and operational planning models for many of the largest pharmaceutical companies year on year. These figures have increased consistently, certainly in the last 5-7 years; as scrutiny from pharmaceutical investors puts increasing pressure on revenue…